Authors: Gupta, Amit Kumar | Kumar, Manoj
Article Type:
Research Article
Abstract:
BACKGROUND: Persistent infection of high-risk HPVs is known to cause diverse carcinomas, mainly cervical, oropharyngeal, penile, etc. However, efficient treatment is still lacking. OBJECTIVE: Identify and analyze potential therapeutic targets involved in HPV oncogenesis and repurposing drug candidates. METHODS: Integrative analyses were performed on the compendium of 1887 HPV infection-associated or integration-driven disrupted genes cataloged from the Open Targets Platform and HPVbase resource. Potential target genes are prioritized using STRING, Cytoscape, cytoHubba, and MCODE. Gene ontology and KEGG pathway enrichment analysis are performed. Further, TCGA cancer genomic data of CESC and HNSCC is
…analyzed. Moreover, regulatory networks are also deduced by employing NetworkAnalyst. RESULTS: We have implemented a unique approach for identifying and prioritizing druggable targets and repurposing drug candidates against HPV oncogenesis. Overall, hundred key genes with 44 core targets were prioritized with transcription factors (TFs) and microRNAs (miRNAs) regulators pertinent to HPV pathogenesis. Genomic alteration profiling further substantiated our findings. Among identified druggable targets, TP53 , NOTCH1 , PIK3CA , EP300 , CREBBP , EGFR , ERBB2 , PTEN , and FN1 are frequently mutated in CESC and HNSCC. Furthermore, PIK3CA , CCND1 , RFC4 , KAT5 , MYC , PTK2 , EGFR , and ERBB2 show significant copy number gain, and FN1 , CHEK1 , CUL1 , EZH2 , NRAS , and H2AFX was marked for the substantial copy number loss in both carcinomas. Likewise, under-explored relevant regulators, i.e., TFs (HINFP, ARID3A, NFATC2, NKX3-2, EN1) and miRNAs (has-mir-98-5p, has-mir-24-3p, has-mir-192-5p, has-mir-519d-3p) is also identified. CONCLUSIONS: We have identified potential therapeutic targets, transcriptional and post-transcriptional regulators to explicate HPV pathogenesis as well as potential repurposing drug candidates. This study would aid in biomarker and drug discovery against HPV-mediated carcinoma.
Show more
Keywords: HPVs, oncogenesis, therapeutic targets, cervical cancer, HNSCC, TCGA, repurposed drugs
DOI: 10.3233/CBM-210413
Citation: Cancer Biomarkers,
vol. 36, no. 1, pp. 31-52, 2023
Price: EUR 27.50